TELA Bio, Inc.

TELA

TELA Bio, Inc.

TELA

Insider Sentiment (TTM):

Last Purchase:2025-11-17Last Sale:2024-07-02Shares Purchased (TTM):3,604,000Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:26,854,356Shares Outstanding:57,256,518Institutional Ownership Pct.:46.90%

Earnings Market Reaction:

Filing Date:2026-08-11Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	30	40	51	30	35	43	53	17	26	37	47	58
Receivables Net Current	10	10	10	11	11	11	10	11	9	10	10	8
Inventory Net	11	12	11	12	11	14	13	14	13	14	13	14
Prepaid Expense And Other Assets Current	3	3	3	4	3	3	3	2	2	2	2	2
Assets Current	54	64	76	56	61	70	78	44	51	63	72	82
Property Plant And Equipment Net	2	2	2	2	2	2	2	2	2	2	2	2
Intangible Assets Net Excluding Goodwill	1	1	1	1	2	2	2	2	2	2	2	2
Operating Lease Right Of Use Asset	1	1	2	2	2	2	2	2	2	2	2	1
Deferred Income Tax Assets Net	-	-	-	0	0	0	0	-	-	-	-	-
Other Assets Noncurrent	0	0	1	-	1	2	2	3	3	3	-	-
Restricted Cash Noncurrent	0	0	0	0	0	0	0	0	0	0	0	-
Assets	60	70	81	62	68	77	87	53	60	72	78	87
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	3	4	2	2	2	4	2	2	2	3	2	3
Accrued Liabilities Current	15	14	16	15	14	13	13	14	13	12	15	12
Long Term Debt Current	-	-	-	-	3	-	-	-	-	-	-	-
Liabilities Current	18	18	18	17	19	17	16	17	15	15	17	15
Long Term Debt Noncurrent	56	56	56	41	38	41	41	41	41	41	41	40
Other Liabilities Noncurrent	1	1	1	2	1	1	1	1	2	2	2	1
Liabilities	76	75	75	60	58	59	58	59	57	57	59	57
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	405	405	404	390	389	388	387	343	342	341	340	338
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	0	0	0	0	0	0	0	0
Retained Earnings Accumulated Deficit	-421	-410	-398	-389	-380	-370	-359	-350	-339	-327	-321	-308
Stockholders Equity	-16	-5	6	2	9	18	28	-6	3	14	19	31
Liabilities And Stockholders Equity	60	70	81	62	68	77	87	53	60	72	78	87
Allowance For Doubtful Accounts Receivable Current	1	0	0	0	0	0	0	0	0	0	0	-
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	45	45	45	40	40	40	39	25	25	25	24	24
Shares Outstanding	45	45	45	40	40	40	39	25	25	25	24	24

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-8.33%	-24.90%	-26.04%	-	-	-	-	-	-	-	-	-
2025	40.26%	98.79%	93.74%	-14.52%	-16.13%	-33.87%	15.12%	14.11%	0.10%	-1.01%	31.16%	24.64%
2024	-4.16%	-18.54%	-20.28%	-11.00%	-12.62%	-6.15%	2.11%	-5.37%	-13.17%	-33.40%	-26.53%	28.57%
2023	-	-	-	-	-	-	23.11%	52.89%	54.22%	-14.14%	0.70%	-2.27%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	2.99	3.61	4.20	3.30	3.19	4.22	5.01	2.62	3.41	4.13	4.23	5.36
Quick Ratio	2.20	2.76	3.40	2.41	2.42	3.23	4.02	1.69	2.37	3.10	3.33	4.32
Working Capital	36.27M	46.47M	57.61M	39.07M	41.68M	53.21M	62.47M	27.27M	36.12M	47.44M	54.76M	66.92M
Leverage & Debt
Debt to Equity	-4.77	-14.44	11.90	38.55	6.35	3.26	2.04	-9.45	19.98	3.99	3.13	1.86
Interest Coverage TTM	-4.81	-5.54	-6.44	0.75	0.36	-3.63	-6.45	-7.11	-7.27	-7.09	-8.44	-8.16
Debt Ratio	1.27	1.07	0.92	0.97	0.86	0.77	0.67	1.12	0.95	0.80	0.76	0.65
Efficiency & Turnover
Asset Turnover TTM	1.26	1.10	0.96	1.34	1.18	0.96	0.84	0.98	0.84	0.97	0.80	0.64
Days Sales Outstanding TTM	47.67	45.78	46.48	53.28	49.26	52.56	52.24	51.29	47.89	48.00	51.07	47.31
Receivables Turnover TTM	7.66	7.97	7.85	6.85	7.41	6.94	6.99	7.12	7.62	7.60	7.15	7.71
Per Share Metrics
Diluted EPS TTM	-0.72	-0.70	-0.83	-0.86	-0.90	-0.96	-1.33	-1.68	-1.71	-1.64	-2.04	-1.79
Free Cash Flow Per Share TTM	-0.53	-0.53	-0.61	-0.48	-0.55	-0.83	-1.49	-1.86	-1.79	-1.81	-1.81	-1.68
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	67.81%	67.25%	67.69%	67.23%	67.30%	66.93%	67.08%	68.31%	68.61%	68.97%	68.62%	69.08%
Operating Profit Margin TTM	-41.92%	-41.70%	-42.05%	4.73%	2.43%	-26.42%	-49.23%	-55.41%	-60.01%	-59.62%	-75.40%	-77.69%
Net Profit Margin TTM	-51.53%	-49.30%	-48.37%	-50.61%	-54.12%	-61.00%	-54.60%	-60.49%	-65.04%	-63.82%	-79.83%	-82.43%
Growth Metrics
Net Revenue Growth (1Y)	6.09%	13.48%	15.84%	12.24%	16.34%	12.78%	18.56%	29.34%	31.64%	40.03%	41.13%	39.05%
Net Income Growth (1Y)	1.01%	-8.30%	2.62%	-6.08%	-3.18%	7.81%	-18.91%	-5.10%	-3.22%	-11.36%	5.35%	1.90%
EPS Growth (1Y)	-20.19%	-27.50%	-37.65%	-48.92%	-47.37%	-41.46%	-34.99%	-5.94%	-8.81%	-30.81%	-25.06%	-30.25%
Valuation Metrics
P/E TTM	-1.05	-0.89	-1.43	-1.74	-2.16	-1.27	-2.28	-1.51	-2.75	-3.46	-3.24	-4.48
P/B TTM	-2.71	-6.83	8.78	43.47	9.58	3.05	3.03	-9.96	40.39	9.69	8.02	6.41
P/S TTM	0.54	0.44	0.69	0.88	1.17	0.78	1.24	0.91	1.79	2.21	2.59	3.69
Market Cap	43.06M	35.50M	55.40M	67.68M	88.01M	55.23M	86.15M	62.50M	115.92M	139.37M	151.39M	195.87M
Enterprise Value	68.52M	51.57M	59.96M	79.21M	94.15M	53.40M	74.34M	85.90M	129.97M	142.62M	144.91M	178.03M
Calculated Values
Free Cash Flow TTM	-30.21M	-30.20M	-28.67M	-21.74M	-24.92M	-37.65M	-42.58M	-46.05M	-44.04M	-44.47M	-41.47M	-41.24M
Net Debt	25.46M	16.08M	4.56M	11.53M	6.14M	-1.82M	-11.81M	23.40M	14.06M	3.26M	-6.48M	-17.84M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-11-17Purchase

Owner: Ew, Healthcare Partners F…

Title: -

Shares: 3,604,000

Price/Share: $1.11

Value: $4,000,440.00

Shares Owned: 7,714,709

Relationship: TenPercentOwner,Other

Ownership: Direct

2024-10-24Purchase

Owner: Cuca, Roberto

Title: COO and CFO

Shares: 64,444

Price/Share: $2.25

Value: $144,999.00

Shares Owned: 155,388

Relationship: Officer

Ownership: Direct

2024-10-24Purchase

Owner: Talmo, Paul

Title: Chief Technology Officer

Shares: 22,222

Price/Share: $2.25

Value: $49,999.50

Shares Owned: 91,082

Relationship: Officer

Ownership: Direct

2024-10-24Purchase

Owner: Firestone, Gregory A.

Title: Chief Commercial Officer

Shares: 6,666

Price/Share: $2.25

Value: $14,998.50

Shares Owned: 57,279

Relationship: Officer

Ownership: Direct

2024-10-24Purchase

Owner: Koblish, Antony

Title: Chief Executive Officer

Shares: 88,888

Price/Share: $2.25

Value: $199,998.00

Shares Owned: 458,897

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-11-17	Ew, Healthcare Partners F…	TenPercentOwner,Other	-	Direct	Purchase	3,604,000	1.11	$4,000,440.00	7,714,709	4
2024-10-24	Cuca, Roberto	Officer	COO and CFO	Direct	Purchase	64,444	2.25	$144,999.00	155,388	4
2024-10-24	Talmo, Paul	Officer	Chief Technology Officer	Direct	Purchase	22,222	2.25	$49,999.50	91,082	4
2024-10-24	Firestone, Gregory A.	Officer	Chief Commercial Officer	Direct	Purchase	6,666	2.25	$14,998.50	57,279	4
2024-10-24	Koblish, Antony	Director,Officer	Chief Executive Officer	Direct	Purchase	88,888	2.25	$199,998.00	458,897	4
2024-07-02	Orbimed, Advisors Llc, Or…	TenPercentOwner	-	Indirect	Sale	36,600	4.54	$166,164.00	2,407,242	4
2023-12-05	Firestone, Gregory A.	Officer	Chief Business Officer	Direct	Purchase	2,600	5.65	$14,690.00	35,511	4
2023-11-14	Koblish, Antony	Director,Officer	Chief Executive Officer	Direct	Purchase	11,000	4.54	$49,940.00	303,634	4
2023-11-14	Cuca, Roberto	Officer	COO and CFO	Direct	Purchase	10,000	4.49	$44,900.00	62,371	4
2023-04-21	Orbimed, Advisors Llc, Or…	TenPercentOwner	-	Indirect	Sale	27,700	9.41	$260,657.00	2,835,542	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

46.90%

Inst. Shares: 26,854,356

Shares Outstanding: 57,256,518

2025-12-31

58.53%

Inst. Shares: 27,476,700

Shares Outstanding: 46,947,932

2025-09-30

51.86%

Inst. Shares: 23,557,279

Shares Outstanding: 45,421,795

2025-06-30

51.51%

Inst. Shares: 23,369,946

Shares Outstanding: 45,365,325

2025-03-31

54.14%

Inst. Shares: 24,507,640

Shares Outstanding: 45,267,020

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	26,854,356	57,256,518	46.90%
2025-12-31	27,476,700	46,947,932	58.53%
2025-09-30	23,557,279	45,421,795	51.86%
2025-06-30	23,369,946	45,365,325	51.51%
2025-03-31	24,507,640	45,267,020	54.14%
2024-12-31	26,868,628	28,526,441	94.19%
2024-09-30	17,884,889	24,703,578	72.40%
2024-06-30	19,600,853	24,663,234	79.47%
2024-03-31	20,415,565	24,579,386	83.06%
2023-12-31	20,691,239	22,868,663	90.48%
2023-09-30	21,596,395	24,483,664	88.21%
2023-06-30	21,974,302	23,239,262	94.56%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

TELA Bio, Inc. (TELA) — SEC Financial Statements & Analysis

TELA Bio, Inc. (TELA) is a surgical & medical instruments & apparatus company, incorporated in DE. TELA Bio, Inc. trades on Nasdaq as: TELA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), TELA Bio, Inc. reported a 6.09% year-over-year revenue growth, a Gross Profit Margin of 67.81% (TTM), a Debt-to-Equity ratio of -4.77x, a Price-to-Sales (P/S) ratio of 0.54x (TTM), a Price-to-Book (P/B) ratio of -2.71x (TTM), at a market cap of $43.06M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 6.09%
Gross Profit Margin TTM: 67.81%
Debt To Equity: -4.77x
P/S TTM: 0.54x
P/B TTM: -2.71x
Market Cap: $43.06M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is TELA Bio, Inc. in?

TELA Bio, Inc. (TELA) operates in the Surgical & Medical Instruments & Apparatus industry.

What is TELA's market cap?

TELA Bio, Inc. (TELA) has a market capitalization of $43.06M as of 2026-06-30.

What exchange does TELA trade on?

TELA Bio, Inc. (TELA) trades on the Nasdaq.

Where is TELA Bio, Inc. incorporated?

TELA Bio, Inc. is incorporated in DE.

TELA Bio, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

TELA Bio, Inc. (TELA) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Surgical & Medical Instruments & Apparatus

Wall Street's data.
Main Street's price.

TELA Bio, Inc. (TELA) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Surgical & Medical Instruments & Apparatus

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.